PRUEBA INMUNOCROMATOGRÁFICA, RÁPIDA, DE UN PASO PARA LA DETECCIÓN DE ANTICUERPOS CONTRA TRYPANOSOMA
Mexico·Clase II·III. Agentes de
diagnóstico·ABBOTT LABORATORIES
DE MÉXICO, S.A. DE C.V.·Registered May 09, 2024- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- BIOLINE™ CHAGAS AB
- Trade Name (English)
- BIOLINE™ CHAGAS AB
- Analysis ID
- 1349R2024 SSA
- Registration Date
- May 09, 2024
- Name (Spanish)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
- Name (English)
- ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for PRUEBA INMUNOCROMATOGRÁFICA, RÁPIDA, DE UN PASO PARA LA DETECCIÓN DE ANTICUERPOS CONTRA TRYPANOSOMA (PRUEBA INMUNOCROMATOGRÁFICA, RÁPIDA, DE UN PASO PARA LA DETECCIÓN DE ANTICUERPOS CONTRA TRYPANOSOMA) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1349R2024 SSA and manufactured by ABBOTT LABORATORIES DE MÉXICO, S.A. DE C.V.. The device was registered on May 09, 2024.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.